id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-339459-z22a5yzo	Mackey, Katherine	Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review	2020-05-15		.txt	text/plain	4138	142	36	JAMA Cardiol Anti-hypertensive angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients Renin-angiotensinaldosterone system blockers and the risk of covid-19 Cardiovascular disease, drug therapy, and mortality in covid-19 Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States veterans aged 54-75 years Renin-angiotensinaldosterone system inhibitors and risk of covid-19 Characteristics and outcomes of a cohort of SARS-CoV-2 patients in the province of Reggio Emilia Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors usage is associated with improved inflammatory status and clinical outcomes in COVID-19 patients with hypertension Hypertension in patients hospitalized with COVID-19 in Wuhan, China: a single-center retrospective observational study Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 COVID-19) Observational studies and trials in adults that examined associations and effects of ACEIs or ARBs on risk for SARS-CoV-2 infection and COVID-19 disease severity and mortality.	cache/cord-339459-z22a5yzo.txt	txt/cord-339459-z22a5yzo.txt
